TXNDC12 was found to have the ability to promote cell migration in cervical cancer cell line and tubule formation in endothelial cells, which can help to give new directions for the treatment of patients with recurrent or refractory cervical cancer in clinic. The gene discussed is TXNDC12; the disease is cervical cancer.